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Iron is a well-established mediator of virulence in several bacterial pathogens, yet little is known about the
role of iron in infectious disease processes caused by obligate intracellular bacterial pathogens. In this study,
the effect of iron limitation was examined for the sexually transmitted infectious agent Chlamydia trachomatis
in an in vitro model of human genital infection using the intracellular iron-chelating reagent deferoxamine me-
sylate (Desferal). Iron restriction caused a significant reduction in infectivity of C. trachomatis elementary bodies
(EB) harvested from Desferal-exposed polarized epithelial cells when compared to that of EB harvested from
iron-sufficient control cell cultures. Replacement of the Desferal exposure medium with medium containing
iron-saturated transferrin restored chlamydial infectivity, whereas replacement with growth medium alone had
no effect. The following three prominent morphological features were observed by electron microscopic exam-
ination of chlamydia-infected cells exposed to Desferal: (i) inclusions containing chlamydiae greatly delayed in
maturation, (ii) substantial blebbing within chlamydial inclusions, and (iii) electron-dense material surround-
ing inclusions. Protein analyses of highly purified EB by two-dimensional polyacrylamide gel electrophoresis
revealed that there were at least 19 candidate iron-repressible proteins in C. trachomatis and at least one
protein which was iron inducible. One putative iron-repressible protein was confirmed by Western blot
(immunoblot) analysis to be the chlamydial heat shock protein 60 (hsp60). The enhanced production of this
antigen by chlamydiae as a result of iron limitation is of particular importance since there is a well-documented
association between chlamydial hsp60 and destructive immunopathological sequelae in infected patients.
Iron, the most abundant metal in biological systems, is inti-
mately involved in numerous cellular metabolic processes.
Since this element is essential for almost all living organisms
examined to date, the oxidative properties of free iron neces-
sitate that intracellular concentrations be tightly regulated and
complexed with high-affinity iron-binding proteins. Otherwise,
iron would interact with reduced forms of oxygen, resulting in
free radicals known to cause lipid peroxidation, protein mod-
ification, and nucleic acid damage (1, 4, 18, 27).
The competition for iron by bacterial pathogens is a subject
of intense examination, and numerous studies have docu-
mented key roles for this element in pathogenesis (for selected
reviews, see references 9, 15, 21, 30, 40, 49, and 52). Besides
the well-recognized example of the relationship between iron
and virulence in regulation of toxin production by Corynebac-
terium diphtheriae (49), studies on gram-negative bacterial en-
velope components involved in iron acquisition suggest that
iron-binding proteins may serve a role in host specificity and
even in colonization of mucosal sites within a given host. For
example, the pathogenic Neisseria species and Haemophilus
influenzae, but not their commensal counterparts, utilize iron
from human transferrin (15, 33). Conversely, Helicobacter py-
lori is unable to sequester iron from human transferrin but may
capitalize on the supply of iron released from lactoferrin in the
acidic compartment of the upper gastrointestinal tract for sur-
vival and growth (25). The importance of iron to mucosal
pathogens has been heightened by two recent findings. First,
specific antibodies against a transferrin-binding protein in the
outer membrane of Neisseria meningitidis elicits protective im-
munity in a mouse model of infection (2, 16, 21). Second, a
transferrin receptor-deficient mutant strain of Neisseria gonor-
rhoeae was not able to initiate urethritis in a human volunteer
challenge study (14).
Chlamydia trachomatis is a major mucosal pathogen. Sero-
variants (or serovars) A to C infect the conjunctiva to cause
trachoma, the leading cause of preventable blindness in the
world. Serovars D to K infect the genital mucosae and are the
leading cause of bacterially acquired sexually transmitted in-
fections (12). The role of iron in the pathogenesis of chlamyd-
iae at mucosal surfaces has not been examined. Also notably
absent in the literature is the role, if any, that iron serves in the
disease processes caused by obligate intracellular bacteria such
as the chlamydiae. Host cell vesicles containing facultative
intracellular bacteria, such as Salmonella typhimurium (42) and
Legionella pneumophila (24), are sufficiently low in iron con-
tent as to enhance the production of iron-regulated virulence
factors in these bacteria. There is also evidence that iron in-
fluences killing or survival of Legionella pneumophila and Lis-
teria monocytogenes in human monocytes and macrophages,
respectively (3, 11). However, C. trachomatis classically resides
in mucosal epithelial cells. Little is understood about how
chlamydiae interact with host cells to obtain nutrients and
metabolites, few chlamydial components have been associated
with virulence properties, and virtually nothing is known about
the mechanisms responsible for host and cellular tropism.
Deciphering iron sequestration by the chlamydiae may be
complicated by the unusual growth of these bacteria in epithe-
lial cells in which the chlamydiae exhibit several morphologic
and metabolic transitions. The unifying characteristic of the
chlamydiae is their developmental cycle, which alternates in a
biphasic asynchronous manner between infectious extracellu-
lar forms, termed elementary bodies (EB), and noninfectious
intracellular forms, termed reticulate bodies (RB). The smaller
* Mailing address: Department of Microbiology and Immunology,
University of North Carolina School of Medicine, Campus Box 7290,
804 Mary Ellen Jones Building, Chapel Hill, NC 27599-7290. Phone:
(919) 966-5041. Fax: (919) 962-8103. E-mail: raulston@med.unc.edu.
4539
EB form is metabolically inert and appears to have a singular
mission in the attachment to and entry into a susceptible mu-
cosal epithelial cell. Once EB are internalized by a receptor-
mediated endocytic route in polarized host epithelial cells,
certain immediate events take place coincident with EB trans-
formation to RB. The chlamydia-containing vesicles appear to
undergo rapid modifications, which include the incorporation
of Golgi-derived lipids from the host exocytic pathway (22).
Although there is a slight initial decrease in vacuolar pH,
vesicles containing viable chlamydiae quickly neutralize their
immediate environment and are not subject to acidification via
the lysosomal pathway (19, 46). For C. trachomatis, individual
vesicles fuse and RB begin to divide by binary fission. The
growth of a single membrane-bound microcolony, termed an
inclusion, can be observed by light microscopy at 18 to 24 h
postinfection (hpi). Recent studies indicate that the inclusion
membrane is a highly selective barrier which does not allow
passive permeation of small molecules (23). Chlamydial RB
eventually condense back to infectious EB, which are released
after 72 to 96 h to infect new host cells. Intermediate chlamyd-
ial forms are observed during transitional phases between EB
and RB and during condensation of RB to EB.
Receptor-mediated internalization of iron bound to trans-
ferrin is the most well understood route for iron acquisition in
eukaryotic cells, although alternative pathways have been iden-
tified and are under investigation (1, 18, 41). In a preliminary
study, Scidmore and Hackstadt (47) showed that the chlamyd-
iae do obtain iron from transferrin; when 55Fe-loaded trans-
ferrin was used as an endosomal marker in chlamydia-infected
cells, the EB progeny isolated after one cycle of development
were radiolabeled. The utilization of iron by chlamydiae is
most likely accomplished by metabolically active RB; yet it is
interesting that several investigators (48, 50, 51) have observed
that transferrin-containing endosomes are positioned immedi-
ately adjacent to developing chlamydial inclusions but are not
obviously fused to inclusions. These observations would gen-
erally suggest that complex transport mechanisms may be in-
volved to transfer iron across (i) the endosomal membrane, (ii)
the inclusion membrane, and (iii) the chlamydial envelope.
There is evidence of a functional membrane transport system
for the transfer of iron from endosomes to the eukaryotic cell
interior (1, 39, 41).
The purpose of this study was to examine whether genital
C. trachomatis serovar E is affected by iron limitation and to
begin to identify specific chlamydial proteins that may be reg-
ulated by iron. Since C. trachomatis serovars D to K are strictly
human pathogens, most of our understanding of chlamydial
biology is derived from in vitro cell culture studies. In this
report, polarized human endometrial epithelial cells were used
as a model for chlamydial infection, and an iron-chelating
reagent, Desferal (deferoxamine mesylate: CIBA Pharmaceu-
tical Co., Summit, N.J.), was used to reduce iron availability to
the chlamydiae. This compound is well documented to specif-
ically chelate labile pools of intracellular iron in eukaryotic
cells, including genital epithelial cells (29, 44). Although in
vitro studies are more simplistic, given the absence of an intact
immune response or hormonal regulation, the availability and
specific sources of iron may very well influence chlamydial
mucosal infection in vivo, as is the case with N. gonorrhoeae. In
addition, it is known that chlamydial attachment and infec-
tivity are substantially increased in estrogen-dominant versus
progesterone-dominant human endometrial gland epithelial
cells (31). Immunohistological studies on human endometrial
tissues obtained from both proliferative and secretory phases
reveal a role for estradiol in the regulation of lactoferrin ex-
pression (26). There is also evidence from an animal model
study that the amount of uterine progesterone is correlated
with expression levels of the intracellular iron storage protein,
ferritin (58). Taken together, these observations support an
investigation into the consequences of the withholding of iron
on chlamydial pathogenesis.
MATERIALS AND METHODS
Bacteria and eukaryotic host cells. C. trachomatis serovar E/UW-5/CX was
provided by C. C. Kuo and S. P. Wang, University of Washington, Seattle. Host
cell cultures were routinely determined to be free of Mycoplasma contamination
by staining with the Hoechst reagent. McCoy cells were used for titrations of
chlamydial infectivity by inclusion formation. Chlamydiae in inclusions were
stained with either Giemsa stain or with a pool of fluorescein-conjugated mono-
clonal antibodies against the C. trachomatis major outer membrane protein
(MOMP; Syva, Palo Alto, Calif.).
Polarized human endometrial epithelial cells were used as the model host cell
system for all iron deprivation experiments (56). The human endometrial carci-
noma cell line HEC-1B (HTB-113; American Type Culture Collection, Rock-
ville, Md.) was grown on collagen-coated (i) Cytodex 3 microcarrier beads in
suspension for purification of EB on a large scale (45, 57) and (ii) Transwell
polycarbonate membranes (Costar, Cambridge, Mass.) for experiments involving
multiple samples (55, 56). A few modifications were necessary for adaptation of
the HEC-1B cells to the recently developed microcarrier culture method. Unlike
the faster-growing McCoy cells, which reach confluency within 3 to 4 days,
HEC-1B epithelial cells require 10 to 14 days of growth on microcarrier beads
before infection with C. trachomatis. Prior to purification of EB, infected
HEC-1B cells require two sequential 15- to 20-min exposures to collagenase and
dispase to remove the firmly anchored cells from the beads. Finally, the number
of beads was kept low, at 5 3 104 per 125-ml culture, to reduce mechanical
shearing of polarized epithelial cells from bead surfaces. Otherwise, the proce-
dure was conducted as outlined previously (45, 57).
Viability experiments. The intracellular iron-chelating reagent Desferal was
used to generate an iron-restricted environment for propagation of C. tracho-
matis serovar E. The effect of Desferal, at concentrations of 25, 50, and 100 mM,
on EB particle yield and subsequent infectivity was first determined with polar-
ized HEC-1B cells on microcarrier beads. This experiment was conducted on two
separate occasions. Cells were infected by adsorption of an EB inoculum for 2 h
followed by incubation at 35°C in Eagle’s minimal essential medium (MEM)
containing 2 mM glutamine, 5% heat-inactivated fetal bovine serum (FBS; Hy-
Clone, Logan, Utah), and 0.5 mg of cycloheximide (Sigma Chemical Co., St.
Louis, Mo.) per ml, and with or without Desferal. The HEC-1B cell line was not
adaptable to growth in serum-free medium. EB were purified with discontinuous
Renografin gradients, and particle counts were obtained with a spectrophoto-
metric standard curve derived from particle counting at the level of electron
microscopy (54). The infectivity of purified EB was determined by diluting
preparations to a multiplicity of 50 EB particles per host McCoy cell and staining
for inclusions with Giemsa stain at 48 hpi.
In a subsequent experiment, holotransferrin (hTf; .99% iron saturated and
endotoxin-free; Sigma) was added to chlamydia-infected cultures to reverse the
effect of Desferal. This experiment was conducted on two separate occasions,
and each parameter was assayed in triplicate. Uninfected HEC-1B cells were
exposed to 100 mM Desferal or 6 mg of hTf per ml for 72 h and assayed for
viability with the LIVE/DEAD Viability/Cytotoxicity Kit of Molecular Probes,
Inc. (Eugene, Oreg.). Polarized HEC-1B cells on Transwell polycarbonate tissue
culture inserts were infected with C. trachomatis by adsorption for 2 h and
subsequently incubated at 35°C in Dulbecco’s modified essential medium with a
high glucose level (DMEM-H; Gibco BRL, Grand Island, N.Y.) containing 2
mM glutamine, 5% FBS, and 0.5 mg of cycloheximide per ml, and with or without
50 mM Desferal. At 24 or 48 hpi, the Desferal exposure medium in certain
samples was replaced with fresh DMEM-H without cycloheximide and with or
without 6 mg of hTf per ml. Samples were subpassaged at 72 or 96 hpi by (i)
removing infected host cells with a rubber policeman, (ii) washing filters with
buffer (2SPG; 0.2 M sucrose, 0.02 M phosphate buffer, 5 mM glutamine [pH
7.2]), (iii) centrifuging each sample with respective washes for 30 min at 15,000 3
g and 4°C, (iv) resuspending each pellet in 200 ml of 2SPG, (v) dispersing each
sample by sonication and mixing on a Vortex mixer, and (vi) diluting each sample
50-fold in 2SPG prior to inoculation of McCoy cell monolayers for infectivity
assessments. A two-tailed Student’s t test was used to determine significance at
a confidence level of 99% (P , 0.01).
Transmission electron microscopy. C. trachomatis serovar E-infected and
-uninfected polarized HEC-1B cells, on polycarbonate membranes, were exam-
ined over (i) a range of Desferal concentrations and (ii) a 72-h time course of
infection. Duplicate samples were washed in phosphate-buffered saline (pH 7.2)
and fixed in 2% glutaraldehyde–0.5% paraformaldehyde for processing and
embedding in Epon-Araldite resin as described in detail by Wyrick et al. (55).
Ultrathin sections were stained with uranyl acetate and lead citrate for high-
contrast morphology and examined with a Zeiss EM900 transmission electron
microscope operated at 60 kV.
Protein and electrophoretic analyses. For metabolic radiolabeling of chlamyd-
iae, polarized HEC-1B cells on microcarrier beads were infected by adsorption
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for 2 h and subsequently incubated in Select-Amine MEM (Gibco BRL). Amino
acid supplements were complete ($100 mM) with the exception of L-methionine
and L-cysteine, which were present at 10 mM. A final concentration of 10 mCi of
[35S]methionine-cysteine (Easytag express protein labeling mix; NEN DuPont
Co., Wilmington, Del.) was added to chlamydia-infected cell cultures after the
2-h adsorption period. The distribution of radiolabel in the mixture was routinely
73% L-[35S]methionine–22% L-[35S]cysteine, and Select-Amine MEM was also
supplemented with 5% FBS, 0.5 mg of cycloheximide per ml, and 0 or 50 mM
Desferal. Mock-infected HEC-1B cells were treated in an identical fashion by
exposure to chlamydial dilution buffer (2SPG) for 2 h prior to the addition of
medium containing [35S]methionine-cysteine.
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) was used to
examine total protein profiles of Renografin-purified C. trachomatis serovar E
EB on four separate occasions; two to three gel profiles of each sample were
examined per experiment. EB were suspended in a mixture containing 9 M urea,
4% (vol/vol) Nonidet P-40, 2% (vol/vol) b-mercaptoethanol, and a 2% (vol/vol)
mixture of ampholytes (Biorad Bio-Lyte and Pharmacia Pharmalyte; pH 3 to 10)
for 2 h at 25°C prior to isoelectric focusing as described previously (43). Tube
gels were then loaded with 8 3 107 EB particles, which is approximately 15 (62)
mg (mean 6 standard deviation) of total EB protein (bicinchoninic acid microas-
say; Pierce, Rockford, Ill.). Concentrations of 15 mg of total cellular protein from
mock-infected HEC-1B cells were also loaded onto tube gels. After separation of
proteins in the first dimension, tube gels were equilibrated for 30 min in a
mixture of 0.125 M Tris-HCl (pH 6.8), 2% (wt/vol) sodium dodecyl sulfate, 10%
(vol/vol) glycerol, 0.01% (wt/vol) bromophenol blue, and 0.8% (vol/vol) b-mer-
captoethanol prior to separation in the second dimension on 12.5% polyacryl-
amide slab gels (28). Low-molecular-weight markers (Bio-Rad) were used for
determination of protein mass in kilodaltons; purified trypsin inhibitor (pI 4.6),
b-lactoglobulin (pI 5.1), and carbonic anhydrase (pI 5.9) were used as isoelectric
markers (Sigma). The pH gradient was also assessed as described previously (43).
Two-dimensional gels were dried onto Whatman paper, covered in Mylar film,
and exposed to Phosphor screens (Eastman Kodak, Rochester, N.Y.) for 48 h.
Phosphorimaging and densitometric analyses of resolved proteins were accom-
plished with a Storm 860 phosphorimaging system and ImageQuaNT software
from Molecular Dynamics (Sunnyvale, Calif.). In some experiments, EB proteins
were examined by silver staining by the procedure outlined by Wray et al. (53).
Western blot analysis. EB proteins resolved by 2D-PAGE were transferred
overnight to nitrocellulose for Western blot (immunoblot) analysis. Following a
1-h blocking period in PBS-Tween 20 plus 2.5% gelatin and three washes in
PBS-Tween 20, the blots were incubated for 2 h with a mixture of the following
primary antibodies: (i) a mouse monoclonal antibody generated against chla-
mydial hsp60, kindly provided by Richard Morrison (University of Alabama,
Birmingham), and (ii) a rabbit-monospecific polyclonal antiserum generated
against gel-purified chlamydial hsp70 protein (43). Antibodies were used at a
1:1,000 dilution in PBS-Tween 20. After washing, blots were incubated for 2 h
with a mixture of goat anti-mouse and goat anti-rabbit alkaline phosphatase-
conjugated secondary antisera; each detection antibody was diluted 1:2,000.
Antigenic reactivity was subsequently visualized following reaction with 5-bro-
mo-4-chloro-3-indolylphosphate–nitroblue tetrazolium.
RESULTS
Effect of iron limitation on infectivity and morphology of
C. trachomatis serovar E. Polarized human endometrial cells
(HEC-1B) were used throughout these studies as target host
cells for human genital chlamydial infection, and Desferal was
used to generate the iron-restrictive environment. Some inves-
tigators report that Desferal, in concentrations greater than 35
mM, is toxic to human monocytes (11), whereas others report
that a very high concentration of Desferal, 2.5 mM, has no
adverse effect on human macrophages (38). In this study, a
72-h exposure to 100 mM Desferal did not compromise
HEC-1B cell viability (data not shown). It is known that eu-
karyotic cells respond to iron restriction with an immediate
increase in the expression of transferrin receptors at the cell
surface to enhance iron sequestration from the external growth
medium (1, 18). Therefore, as an additional measure to ensure
iron restriction, a 0.5-mg/ml concentration of cycloheximide,
which has no inhibitory activity to chlamydiae (45), was in-
cluded in these studies to inhibit host cell protein synthesis and
reduce the rate of iron uptake from the growth medium.
In the first set of experiments, the effect of increasing con-
centrations of Desferal on EB particle yield and infectivity was
examined. There were no significant differences in the absolute
number of developing inclusions between normal and Des-
feral-exposed chlamydia-infected cultures (data not shown)
(P , 0.01). However, inclusions developing in the presence of
Desferal appeared smaller by light microscopy. C. trachomatis
serovar E EB from iron-sufficient and Desferal-exposed cul-
tures were highly purified by Renografin gradient centrifuga-
tion at 62 and 70 hpi. After particle counts were obtained,
purified EB were diluted to a multiplicity of infection of 50:1 to
determine the resultant infectivity in each preparation. The
results presented in Table 1 document that the number of EB
particles from iron-restricted, infected epithelial cell cultures
was less than the number of EB particles purified from iron-
sufficient, control cell cultures. Most importantly, the subse-
quent infectivity of EB following subpassage onto fresh cell
monolayers was considerably reduced in a dose-dependent
manner as the concentration of Desferal was increased. An
examination of the EB preparations by fluorescence micros-
copy, using monoclonal antibodies generated against the MOMP,
confirmed that although more particles were obtained from
cultures exposed to 100 mM Desferal than from those exposed
to 25 mM desferal, the EB were notably irregular in shape
(data not shown).
To more closely examine the morphological features of chla-
mydiae propagated in the presence of Desferal, studies were
extended to the level of electron microscopy (Fig. 1). Unin-
fected HEC-1B cells exposed to 100 mM Desferal for 72 h
showed that ultrastructural features were well maintained
(compare Fig. 1A and B). Chlamydia-infected polarized HEC-
1B cells, in the presence or absence of Desferal, were exam-
ined at 24, 48, and 72 hpi. A normal 72-h inclusion of C. tra-
chomatis serovar E, containing condensed EB and a few RB, is
illustrated in Fig. 1C. In the Desferal-exposed cultures, three
very prominent morphological features were observed. After a
72-h incubation, chlamydial inclusions contained either (i) an
abnormal quantity of membrane blebs, presumably chlamydial
in origin (Fig. 1D, enlargement in inset), or (ii) inclusions
containing predominantly RB (Fig. 1E). The latter observation
reflects a considerable delay in maturation for 72 hpi. In ad-
dition, the outer membranes surrounding individual RB in
Desferal-exposed cultures were dense and wavy relative to
those surrounding normal RB (compare insets in Fig. 1C and
TABLE 1. Infectivity and total number of EB particles of
C. trachomatis serovar E harvested from HEC-1B














1 62 0 (control) 1.8 3 109 56
25 8.3 3 107 24
50 3.4 3 108 12
100 2.0 3 108 7
2 70 0 (control) 1.4 3 109 40
25 4.2 3 107 21
50 2.2 3 107 19
100 3.6 3 108 13
a Approximately 5 3 107 polarized HEC-1B cells on porous Cytodex 3 beads
were infected by adsorption with an inoculum of C. trachomatis serovar E which
would result in 50% infected cells. Infected cultures were incubated at 35°C in
Eagle’s MEM with or without Desferal.
b EB were purified by Renografin density gradient centrifugation.
c Total EB particles were determined spectrophotometrically by extrapolation
from a standard curve of particle counts obtained by electron microscopy.
d EB infectivity was determined by the number of inclusions formed per 100
McCoy cells by use of a multiplicity of infection of 50 EB particles per host cell.
Values reflect the average inclusion count from 10 microscopic grid fields at 340
magnification.
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FIG. 1. Ultrastructural analysis of C. trachomatis serovar E in polarized HEC-1B cells exposed to the intracellular iron-chelating reagent Desferal. Uninfected (A
and B) and C. trachomatis-infected (C to F) polarized endometrial epithelial cells were fixed, processed, and embedded for high-contrast transmission electron
microscopic examination of ultrathin sections. (A to C) Controls included uninfected HEC-1B cells (A), uninfected HEC-1B cells exposed to 100 mM Desferal for 72 h
(B), and C. trachomatis-infected cells at 72 hpi (C). In panel C, the typical chlamydial inclusion contains condensed EB (arrowheads) and larger RB (arrows); the inset
is an enlargement of a normal RB to illustrate standard envelope ultrastructure. (D and E) C. trachomatis inclusions after 72 h of exposure to 100 mM Desferal
contained numerous intrainclusion blebs (D; enlargement shown in inset) or predominantly RB (E). RB growing in the presence of Desferal exhibited loose and wavy
outer membranes (compare inset in panel E to inset in panel C). (F) Electron-dense material surrounding a small inclusion after 24 h of exposure to 100 mM Desferal
is shown (arrowheads). Bars, 2.0 mm.
4542 RAULSTON INFECT. IMMUN.
E), indicating a potential increase in synthesis of the chlamyd-
ial envelope in response to Desferal exposure. The third ultra-
structural feature was the presence of dense material at the
periphery of the inclusion membrane (Fig. 1F); this material
was observed surrounding inclusions as early as 24 hpi.
Although the adverse viability and morphological observa-
tions provided evidence that the chlamydiae may be affected by
iron availability, the question still remained as to whether these
bacteria responded specifically to iron limitation versus an
indirect metabolic consequence of a compromised host cell
environment. To confirm that the observed effects resulted
from iron deprivation, experiments were conducted to restore
chlamydial viability by replacing the culture medium contain-
ing 50 mM Desferal with medium containing 6 mg of iron-
saturated hTf per ml, since transferrin is at least one source of
iron for the chlamydiae (47). A 6-mg/ml concentration of hTf
exceeds the iron-binding capacity of 50 mM Desferal by three-
fold on an equimolar basis. Importantly, toxicity was not ob-
served in HEC-1B cells exposed to 6 mg of hTf-containing
medium per ml for 72 h (data not shown). The medium was
replaced to remove cycloheximide so that host cell synthesis,
and therefore iron acquisition and utilization, were resumed.
Several intervals of time for the addition of hTf, as well as
for subpassage of chlamydiae, were included in this experiment
since (i) normal chlamydial development and the appearance
of metabolically active RB occur in an asynchronous manner
and (ii) electron microscopic examination showed that Des-
feral delayed chlamydial maturation. To simplify the presen-
tation of these data, a schematic of the experimental design is
shown in Fig. 2A. The results of the experiment, shown in Fig.
2B, confirmed that exposure of C. trachomatis-infected, polar-
ized HEC-1B cells to 50 mM Desferal for 72 h caused a sig-
nificant reduction in infectivity (Fig. 2B, compare samples 1
and 5; P , 0.01). Most importantly, the addition of hTf at 24
hpi led to a significant recovery of chlamydial infectivity at 72
hpi (Fig. 2B, compare samples 5 and 7), which was more
dramatic at 96 hpi (compare samples 9 and 11; P , 0.01).
There was no significant recovery of infectivity by replacement
of the growth medium alone (Fig. 2B, compare samples 5 and
6 and samples 9 and 10; P , 0.01). Under normal growth
conditions, C. trachomatis serovar E inclusions at 48 hpi con-
tain a mixture of EB, RB, and intermediate forms; presumably,
only the metabolically active RB would respond to the in-
creased availability of iron. If hTf was added to infected cell
cultures at 48 hpi, at least 48 h of further incubation was
required for improved recovery of infectious EB (Fig. 2B,
compare samples 8 and 12). The removal of cycloheximide also
restored competition between chlamydiae and the host cell for
metabolites (Fig. 2B, compare samples 1 and 2). Overall, these
data suggest that the detrimental effects of Desferal on chla-
mydial viability and infectivity are due primarily to the with-
holding of iron from chlamydiae via the eukaryotic host cell.
Two-dimensional analyses of C. trachomatis serovar E EB
proteins following iron limitation. Since it is well documented
that iron restriction leads to the enhanced production of spe-
cific proteins, many of which are virulence factors in other
bacteria, total protein profiles of highly purified EB from iron-
sufficient and iron-limited polarized HEC-1B cells were ana-
lyzed by 2D-PAGE. All samples were adjusted by dilution to
an equivalent particle-per-particle basis prior to resolution by
2D-PAGE. Since Desferal exposure appeared to alter the ul-
trastructural features of the chlamydial envelope, one might
expect a higher quantity of outer membrane proteins, in par-
ticular, in EB purified from iron-limited than from iron-suffi-
cient host cells by this method of comparison.
Representative 2D-PAGE phosphorimages of C. trachoma-
tis 35S-labeled EB proteins are presented in Fig. 3 A and B, and
enlargements of high-molecular-weight proteins are provided
in Fig. 4A and B. Total protein in EB purified from HEC-1B
cells under normal growth conditions is shown in Fig. 3A and
4A, and EB protein from cells exposed to 50 mM Desferal is
shown in Fig. 3B and 4B. For comparison, total cellular protein
from mock-infected polarized HEC-1B cells, in the absence
(Fig. 3C) or presence (Fig. 3D) of Desferal, was examined. The
total mock-infected HEC-1B cell population was solubilized
for 2D-PAGE since there was no detectable host cell material
at the Renografin gradient interface where chlamydiae migrate
during centrifugation and purification. Although a small de-
gree of labeling was observed for mock-infected HEC-1B cells,
even in the presence of 0.5 mg of cycloheximide per ml, there
were no exact protein matches between the mock-infected host
cells (Fig. 3C and D) and the purified C. trachomatis 35S-
labeled EB (Fig. 3A and B).
Densitometric values obtained by phosphorimaging con-
firmed that there was an average 1.5-fold increase in the quan-
tity of the MOMP (40 kDa) in EB from Desferal-exposed
cultures compared with that in EB from iron-sufficient cultures
FIG. 2. Recovery of C. trachomatis serovar E infectivity, after Desferal ex-
posure of infected polarized HEC-1B cells, by replacement of the culture me-
dium with medium containing iron-saturated transferrin. (A) Schematic of the
experimental design. M, DMEM-H (see Materials and Methods); Cx, 0.5 mg of
cycloheximide per ml; hTf, 6 mg of hTf per ml; D, 50 mM Desferal. Percentages
represent the average number of inclusions per 100 McCoy cells following direct
passage of a 1:50 dilution of harvested chlamydiae (i.e., percent infectivity). (B)
Presentation of the data in a bar graph format. The error bars represent 1
standard deviation of the data from each sample.
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(Fig. 4B and A, respectively). It is not yet known whether the
MOMP is regulated by iron at the level of transcription, but for
further protein comparisons, the quantity of MOMP was used
as an internal control. The candidate iron-repressible chlamyd-
ial protein species highlighted in this study (Fig. 3B and 4B)
were either (i) present in EB purified from Desferal-exposed
cell cultures and absent or undetectable in EB purified from
host cells under normal growth conditions or (ii) quantitatively
threefold greater in EB from iron-restricted cultures than in
EB from iron-sufficient cultures. By these criteria, there were
at least 19 chlamydial proteins that exhibited enhanced expres-
sion due to Desferal-mediated iron limitation. Three proteins
were detectable only by silver staining (data not shown). A
summary of size and charge characteristics of the 19 putative
iron-repressible chlamydial proteins is provided in Table 2.
Interestingly, there was at least one chlamydial protein that
was induced under iron-sufficient growth conditions (Fig. 3A;
enlarged in Fig. 4A).
The 60-kDa protein. One chlamydial protein that showed a
considerable increase in expression as the result of iron limi-
tation was 60 kDa in mass with an acidic isoelectric point (pI)
of 5.4 (Fig. 4B). These properties are characteristic of the chla-
mydial heat shock protein (hsp60) or GroEL (5, 8). Proteins
resolved by 2D-PAGE were transferred to nitrocellulose for
Western blot analysis to confirm the identity of this protein
species. Blots were probed simultaneously with a monoclonal
antibody directed against chlamydial hsp60 and monospecific
antiserum directed against chlamydial hsp70, as a control, for
proper orientation of the blots. The result, illustrated in Fig.
4C and D, confirmed that the 60-kDa protein was indeed the
chlamydial hsp60 homolog. Although there was a slight in-
crease in production of the hsp70 protein following iron limi-
tation, the quantitative difference did not meet the criteria
outlined above, and, thus, hsp70 was not highlighted as an iron-
regulated candidate.
DISCUSSION
The data presented in this study (i) demonstrate that C.
trachomatis serovar E development and infectivity are ad-
versely affected by iron limitation and (ii) provide evidence for
the existence of chlamydial proteins regulated by iron avail-
ability. It is known that iron chelation by Desferal in eukaryotic
cells is exclusively intracellular and does not remove iron from
serum-containing growth medium (29, 41), which was impor-
tant in this study since HEC-1B cells were not adaptable to
growth in serum-free medium. There is some evidence that
Desferal may actually cause extrusion of iron from cells into
the growth medium (20). One concern regarding the use of
Desferal was a documented interference with ribonucleotide
reductase activity (13). Iron is part of the active center of this
enzyme which reduces ribonucleotide diphosphates to deoxy-
ribonucleotide diphosphates. However, the chlamydiae do not
transport deoxyribonucleotides from host cells; instead, these
organisms are thought to have their own ribonucleotide
reductase (32). Although it is still possible that Desferal com-
promises chlamydial development by alternative activities on
iron-requiring host cell enzymes, the significant recovery of
chlamydial infectivity by providing transferrin to the system
FIG. 3. Detection of putative iron-repressible proteins in purified C. tracho-
matis serovar E metabolically 35S-radiolabeled EB by phosphorimage analysis of
2D-PAGE profiles. Purified EB were obtained from chlamydia-infected polar-
ized HEC-1B cell cultures under normal growth conditions (A) and in the
presence of 50 mM Desferal (B). Controls included mock-infected polarized
HEC-1B cells unexposed (C) or exposed (D) to 50 mM Desferal for 72 h.
Densitometric values of total EB proteins in panel B were compared with
proteins in panel A; at least 15 proteins (6 designated by arrows and 9 contained
within the bracketed area) were detected in EB from iron-restricted cultures (B)
but were either absent or quantitatively threefold less in normal EB (A). One
iron-inducible protein is illustrated in panel A (circle).
FIG. 4. High-molecular-weight putative iron-repressible proteins and confir-
mation of one such protein as the chlamydial heat shock protein 60 (hsp60) by
Western blot analysis. Proteins were resolved by 2D-PAGE from purified C. tra-
chomatis serovar E EB grown in polarized HEC-1B cells under normal condi-
tions (A and C) or in the presence of 50 mM Desferal (B and D). (A and B)
Enlarged profiles of 35S-radiolabeled EB proteins detected by phosphorimaging.
Iron-repressible proteins are indicated by arrowheads in panel B, and the iron-
inducible protein is circled in panel A. (C and D) Western blot reactivity of the
C. trachomatis hsp60 and hsp70 proteins following transfer of 2D-PAGE proteins
to nitrocellulose, incubation with a mouse monoclonal antibody to hsp60 and a
rabbit monospecific polyclonal antibody to hsp70, and detection by alkaline
phosphatase-conjugated secondary antibodies.
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argues that the effects observed are due primarily to reducing
iron availability to the chlamydiae.
There is only one additional study on the effect of the with-
holding of iron on chlamydial development. Murray et al. (37)
used Desferal to restrict iron availability to Chlamydia psittaci
growing in gamma interferon-activated macrophages. By stain-
ing and counting inclusions, these authors reported no differ-
ence in the numbers of inclusions that developed within iron-
restricted and control macrophages. In the present study, there
was also no difference in the absolute numbers of C. tracho-
matis inclusions that formed within iron-restricted and iron-
sufficient epithelial cells. However, microscopic examination
clearly illustrated that C. trachomatis inclusion development
was impaired in the presence of Desferal. The observation that
a higher number of EB particles was obtained from cultures
exposed to 100 mM Desferal than from cultures exposed to 25
mM Desferal might suggest that if iron is severely limited,
chlamydial development is prematurely terminated, leading to
incomplete maturation or condensation of RB to normal in-
fectious EB, whereas under less-extreme conditions of iron re-
striction, chlamydial development is merely delayed. The most
crucial finding was that chlamydial infectivity was reduced as
the removal of iron, by increasing the concentration of Des-
feral, was increased. Taken together, these observations pro-
vide a hypothesis that the spread of chlamydial infection in
genital epithelial cells may be reduced under conditions of iron
limitation. Although this study employed the use of a chemical
chelator, evidence from other studies (26, 58) indicates that
estradiol and progesterone modulate the sources of, and avail-
ability of, iron in endometrial tissue in vivo, respectively.
A decrease in chlamydial infectivity due to iron restriction
might initially be viewed as favorable. However, the enhanced
production of chlamydial hsp60 due to the withholding of iron
raises considerable concern. This antigen provokes an inflam-
matory response in an animal model of ocular infection (35,
36), and patient antibody production to chlamydial hsp60 is
associated with destructive sequelae such as pelvic inflamma-
tory disease, infertility, and ectopic pregnancy (reviewed in
reference 10). There is evidence for the existence of abnor-
mally large, persistent chlamydial forms which may contribute
to immune damage by providing a steady dose of chlamydial
antigen (7). In an in vitro model of C. trachomatis persistence
mediated by gamma interferon, expression of the hsp60 anti-
gen remains steady while synthesis of other major antigens
declines (6). Although unusual chlamydial inclusion develop-
ment was observed in Desferal-exposed cells in this study, the
underlying mechanism appears to differ from that of gamma
interferon since (i) the morphology of RB under conditions of
iron limitation did not resemble the persistent forms induced
by gamma interferon and (ii) expression of the MOMP is
increased. Regardless of the mechanism, increased synthesis of
chlamydial hsp60 as a result of iron restriction may contribute
to the destructive immune-mediated pathology of chlamydial
disease.
In other bacteria, iron-repressible proteins are controlled at
the level of transcription by a repressor similar to Escherichia
coli Fur (ferric uptake regulator) protein. In the presence of
sufficient iron, Fur protein multimers bind to the promoter
region of iron-regulated genes with ferrous iron as a cofactor
(30), and a 19-bp DNA Fur-binding consensus sequence has
been established (17). For comparison, the upstream sequence
regions of available chlamydial GroES/GroEL (hsp60) genes
were examined for Fur-binding consensus sequences. The most
convincing matches were observed in C. psittaci GPIC (35).
Although such evidence is indirect, these sequences indicate
that, like other bacteria, the chlamydiae may have transcrip-
tional regulatory mechanisms for the expression of specific
proteins under iron limitation. Studies to identify a chlamydial
iron repressor are presently under way.
At least 19 putative iron-repressible proteins were observed
for C. trachomatis serovar E by exposure of infected epithelial
cells to Desferal. It is possible that additional iron-repressible
proteins remain undetected. Alternative iron-chelating com-
pounds have not yet been examined; agents such as a,a9-
dipyridyl or phenanthroline, which are lipophilic and pref-
erentially chelate iron from membrane-bound components,
may reveal additional iron-repressible chlamydial proteins. Of
the chlamydial protein species highlighted in this study, several
merit further examination. For example, one protein is 37 kDa
in size and has an unusually basic pI; the periplasmic ferric-
binding protein (Fbp) of N. gonorrhoeae is 37 kDa in size and
has a pI of greater than 9.35 (34). In addition, the transferrin-
and lactoferrin-binding proteins in other bacteria are consis-
tently 65 to 85 kDa or 100 kDa in size (21), and there are at
least three chlamydial proteins with masses of 65 to 85 kDa
that exhibit enhanced expression due to iron limitation. This
study supports the finding of Scidmore and Hackstadt (47) that
transferrin is at least one major source of iron for the chla-
mydiae. Whether transferrin is an exclusive source of iron or
alternative complexes such as lactoferrin or heme provide iron
to the chlamydiae is not yet known. Overall, the present study
provides a foundation and the feasibility to further pursue
specific components subject to iron regulation to better our
understanding of the cellular microbiology of chlamydial in-
fection.
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a Proteins which were quantitatively threefold greater in EB purified from
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iron-sufficient polarized HEC-1B cell cultures, as determined by densitometric
values following phosphorimage analyses, are characterized.
b Protein detected by silver staining only.
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cultures.
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